These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21161184)

  • 1. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
    Ricci V; Martinotti G; Gelfo F; Tonioni F; Caltagirone C; Bria P; Angelucci F
    Psychopharmacology (Berl); 2011 May; 215(1):143-8. PubMed ID: 21161184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers.
    Ke X; Ding Y; Xu K; He H; Zhang M; Wang D; Deng X; Zhang X; Zhou C; Liu Y; Ning Y; Fan N
    Drug Alcohol Depend; 2014 Sep; 142():290-4. PubMed ID: 25064020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPA receptor potentially participates in the mediation of the increased brain-derived neurotrophic factor following chronic ketamine use.
    Yang J; Zhou Z; Yang C
    Psychopharmacology (Berl); 2012 Mar; 220(1):243; author reply 245. PubMed ID: 22009000
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
    Duncan WC; Sarasso S; Ferrarelli F; Selter J; Riedner BA; Hejazi NS; Yuan P; Brutsche N; Manji HK; Tononi G; Zarate CA
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):301-11. PubMed ID: 22676966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.
    Angelucci F; Ricci V; Martinotti G; Palladino I; Spalletta G; Caltagirone C; Bria P
    Addict Biol; 2010 Jul; 15(3):365-7. PubMed ID: 20477754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
    Fuller JJ; Murray RC; Horner KA
    Neuropharmacology; 2015 Oct; 97():7-17. PubMed ID: 25986696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis.
    Jhang JF; Wang HJ; Hsu YH; Birder LA; Kuo HC
    Neurourol Urodyn; 2019 Nov; 38(8):2303-2310. PubMed ID: 31433072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.
    Angelucci F; Ricci V; Spalletta G; Pomponi M; Tonioni F; Caltagirone C; Bria P
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):882-7. PubMed ID: 18774699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
    Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
    J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum level of epidermal growth factor in chronic ketamine users.
    Zhang M; He H; Ning Y; Ding Y; Ke X; Wang D; Deng X; Fan N
    Hum Psychopharmacol; 2018 May; 33(3):e2656. PubMed ID: 29602228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Fan N; Luo Y; Xu K; Zhang M; Ke X; Huang X; Ding Y; Wang D; Ning Y; Deng X; He H
    Schizophr Res; 2015 Dec; 169(1-3):10-15. PubMed ID: 26589393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX; Wang J; Xie ZM; Xu N; Zhang GF; Jia M; Zhou ZQ; Hashimoto K; Yang JJ
    Psychopharmacology (Berl); 2016 Feb; 233(3):405-15. PubMed ID: 26514555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms.
    Wu K; Len GW; McAuliffe G; Ma C; Tai JP; Xu F; Black IB
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):178-86. PubMed ID: 15519688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.
    Xu K; Lipsky RH
    Exp Biol Med (Maywood); 2015 Feb; 240(2):145-55. PubMed ID: 25245072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo.
    Messaoudi E; Ying SW; Kanhema T; Croll SD; Bramham CR
    J Neurosci; 2002 Sep; 22(17):7453-61. PubMed ID: 12196567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS.
    Lessmann V
    Gen Pharmacol; 1998 Nov; 31(5):667-74. PubMed ID: 9809461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.
    Ciszowski K; Gomółka E; Gawlikowski T; Szpak D; Potoczek A; Boba M
    Przegl Lek; 2016; 73(8):552-9. PubMed ID: 29677430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations.
    Le Nedelec M; Glue P; Winter H; Goulton C; Broughton L; Medlicott N
    Drug Deliv Transl Res; 2018 Jun; 8(3):780-786. PubMed ID: 29322484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.